Seres Therapeutics (MCRB)
(Delayed Data from NSDQ)
$0.83 USD
-0.08 (-9.10%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $0.88 +0.05 (5.77%) 5:30 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.24 | 0.00% |
Earnings Summary
For their last quarter, Seres Therapeutics (MCRB) reported earnings of -$0.22 per share, beating the Zacks Consensus Estimate of $-0.28 per share. This reflects a positive earnings surprise of 21.43%. Look out for MCRB's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.24 per share, reflecting a year-over-year increase of 35.14%.
Earnings History
Price & Consensus
Zacks News for MCRB
Bears are Losing Control Over Seres Therapeutics (MCRB), Here's Why It's a 'Buy' Now
MCRB: What are Zacks experts saying now?
Zacks Private Portfolio Services